Eleonore Pauwels

Eleonore Pauwels is the Research Fellow on Emerging Cybertechnologies at the Centre for Policy Research at United Nations University, focusing on artificial intelligence. She is also director of the AI Lab at the Woodrow Wilson International Centre for Scholars. Her research analyses and compares how emerging technologies, such as AI and genome-editing, raise new opportunities and challenges for health, security, economics and governance in different geo-political contexts. Pauwels is an adviser on the AI Initiative at Harvard Kennedy School, the IEEE Global Initiative on Ethics of Autonomous and Intelligent Systems, as well as an expert for the World Economic Forum.
Eleonore Pauwels
Eleonore Pauwels is the Research Fellow on Emerging Cybertechnologies at the Centre for Policy Research at United Nations University, focusing on artificial intelligence. She is also director of the AI Lab at the Woodrow Wilson International Centre for Scholars. Her research analyses and compares how emerging technologies, such as AI and genome-editing, raise new opportunities and challenges for health, security, economics and governance in different geo-political contexts. Pauwels is an adviser on the AI Initiative at Harvard Kennedy School, the IEEE Global Initiative on Ethics of Autonomous and Intelligent Systems, as well as an expert for the World Economic Forum.

Latest from Eleonore Pauwels

China pins its hopes on beating US in race for bio-intelligence supremacy
Opinion | China is pushing hard to overtake Silicon Valley and win the biotech race, and gain control of the world’s biological data

The world should pay attention, as China achieves dominance in AI and biotech. Bio-intelligence is more than mapping genomes: whoever controls the resources may influence the well-being of entire populations.

23 Nov 2018 - 9:26AM

The world should pay attention, as China achieves dominance in AI and biotech. Bio-intelligence is more than mapping genomes: whoever controls the resources may influence the well-being of entire populations.

China is pushing hard to overtake Silicon Valley and win the biotech race, and gain control of the world’s biological data